1. Home
  2. CHRS vs STRS Comparison

CHRS vs STRS Comparison

Compare CHRS & STRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.40

Market Cap

186.0M

Sector

Health Care

ML Signal

HOLD

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

N/A

Current Price

$24.74

Market Cap

168.1M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CHRS
STRS
Founded
2010
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Homebuilding
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
186.0M
168.1M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CHRS
STRS
Price
$1.40
$24.74
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$4.02
N/A
AVG Volume (30 Days)
859.2K
14.6K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.34
N/A
Revenue
$277,728,000.00
$31,912,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$67.31
N/A
P/E Ratio
$1.00
N/A
Revenue Growth
152.07
N/A
52 Week Low
$0.71
$15.10
52 Week High
$1.89
$26.30

Technical Indicators

Market Signals
Indicator
CHRS
STRS
Relative Strength Index (RSI) 56.03 63.58
Support Level $1.27 $24.45
Resistance Level $1.43 $25.63
Average True Range (ATR) 0.08 0.93
MACD 0.01 -0.05
Stochastic Oscillator 71.05 68.69

Price Performance

Historical Comparison
CHRS
STRS

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

Share on Social Networks: